(631937, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43902439024390244, 8.144985856518405, 1.890991128800768, 'UPHENO:0046362', 'abnormal protein level'),
(631938, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0012616', 'increased circulating factor IX level', 0.4090909090909091, 8.144985856518405, 1.8253875392846615, 'UPHENO:0046362', 'abnormal protein level'),
(631939, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0011892', 'abnormal circulating transferrin level', 0.43902439024390244, 8.144985856518405, 1.890991128800768, 'UPHENO:0046362', 'abnormal protein level'),
(631940, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0014160', 'abnormal circulating cortisol level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(631941, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0008820', 'abnormal blood uric acid level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(631942, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4090909090909091, 8.144985856518405, 1.8253875392846615, 'UPHENO:0046362', 'abnormal protein level'),
(631943, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4090909090909091, 8.144985856518405, 1.8253875392846615, 'UPHENO:0046362', 'abnormal protein level'),
(631944, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0020984', 'decreased circulating factor XI level', 0.4090909090909091, 8.144985856518405, 1.8253875392846615, 'UPHENO:0046362', 'abnormal protein level'),
(631945, 'HP:0030684', 'Abnormal adiponectin level', 'MP:0011889', 'abnormal circulating ferritin level', 0.43902439024390244, 8.144985856518405, 1.890991128800768, 'UPHENO:0046362', 'abnormal protein level'),
(631946, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631947, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631948, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631949, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631950, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631951, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631952, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631953, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631954, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631955, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631956, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631957, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631958, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631959, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631960, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631961, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631962, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631963, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031117', 'subdural hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631964, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020424', 'increased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631965, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631966, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631967, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631968, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631969, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631970, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002195', 'psychomotor seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631971, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631972, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631973, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631974, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631975, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631976, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631977, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004859', 'abnormal synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631978, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631979, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631980, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631981, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631982, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631983, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631984, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631985, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631986, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631987, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631988, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631989, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631990, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631991, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631992, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631993, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631994, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631995, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631996, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631997, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(631998, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(631999, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632000, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632001, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632002, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632003, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632004, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632005, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632006, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632007, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632008, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632009, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632010, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632011, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632012, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632013, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632014, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632015, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632016, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632017, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632018, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632019, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632020, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632021, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632022, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632023, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632024, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632025, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632026, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632027, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632028, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632029, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632030, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001500', 'decreased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632031, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632032, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632033, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632034, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632035, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021009', 'abnormal synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632036, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004494', 'abnormal synaptic glutamate release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632037, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632038, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632039, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632040, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632041, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632042, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632043, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632044, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632045, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632046, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632047, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632048, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632049, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632050, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632051, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632052, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632053, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632054, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632055, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632056, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632057, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632058, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632059, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632060, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632061, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632062, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632063, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632064, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632065, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632066, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632067, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002635', 'reduced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632068, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632069, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632070, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632071, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632072, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632073, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632074, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632075, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632076, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632077, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632078, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632079, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632080, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632081, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632082, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632083, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632084, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632085, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632086, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632087, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632088, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632089, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002915', 'abnormal synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632090, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632091, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632092, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632093, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632094, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632095, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632096, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632097, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632098, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632099, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632100, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632101, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632102, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632103, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632104, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632105, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632106, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632107, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632108, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632109, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632110, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632111, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632112, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632113, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632114, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632115, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632116, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632117, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632118, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632119, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632120, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632121, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632122, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632123, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632124, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632125, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632126, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632127, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632128, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632129, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632130, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632131, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632132, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632133, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632134, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632135, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632136, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632137, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632138, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632139, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632140, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632141, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632142, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632143, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632144, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632145, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632146, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632147, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632148, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632149, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632150, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632151, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632152, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632153, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632154, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632155, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632156, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632157, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632158, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632159, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632160, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632161, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632162, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632163, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632164, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632165, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632166, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632167, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632168, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632169, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632170, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632171, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632172, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632173, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632174, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632175, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632176, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632177, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632178, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632179, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632180, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632181, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632182, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632183, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632184, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632185, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632186, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632187, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632188, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632189, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632190, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632191, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632192, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632193, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632194, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632195, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632196, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632197, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632198, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632199, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632200, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632201, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632202, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632203, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632204, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632205, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632206, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632207, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632208, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632209, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632210, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632211, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632212, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632213, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632214, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632215, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632216, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632217, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632218, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632219, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632220, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632221, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632222, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632223, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632224, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632225, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632226, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632227, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632228, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632229, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632230, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632231, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632232, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632233, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632234, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012261', 'increased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632235, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632236, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632237, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632238, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632239, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632240, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632241, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632242, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632243, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632244, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010654', 'slow Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632245, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632246, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632247, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632248, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632249, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632250, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632251, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632252, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632253, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632254, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632255, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632256, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632257, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632258, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632259, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632260, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632261, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632262, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632263, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632264, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632265, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632266, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632267, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632268, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632269, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632270, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632271, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632272, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632273, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632274, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632275, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632276, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632277, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632278, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632279, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632280, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632281, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632282, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632283, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632284, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632285, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632286, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632287, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632288, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632289, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632290, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632291, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632292, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632293, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632294, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632295, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632296, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632297, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003476', 'decreased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632298, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632299, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632300, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632301, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632302, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632303, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632304, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632305, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632306, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632307, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632308, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632309, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632310, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632311, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632312, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632313, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632314, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632315, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632316, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632317, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632318, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632319, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632320, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632321, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632322, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632323, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632324, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632325, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632326, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632327, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632328, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632329, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632330, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632331, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632332, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632333, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632334, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632335, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632336, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632337, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632338, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632339, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632340, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632341, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632342, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632343, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632344, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632345, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632346, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632347, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632348, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632349, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632350, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632351, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632352, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632353, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008840', 'abnormal spike wave discharge', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632354, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632355, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632356, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632357, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632358, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632359, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632360, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632361, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632362, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632363, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632364, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632365, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632366, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632367, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632368, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632369, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632370, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632371, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632372, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632373, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632374, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632375, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005402', 'abnormal action potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632376, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632377, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632378, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632379, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632380, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632381, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632382, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632383, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003477', 'abnormal nerve fiber response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632384, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011994', 'increased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632385, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632386, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632387, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632388, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632389, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632390, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632391, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632392, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632393, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632394, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632395, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632396, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632397, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632398, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632399, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003473', 'decreased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632400, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632401, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632402, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632403, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632404, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632405, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632406, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632407, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632408, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632409, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632410, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632411, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632412, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632413, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632414, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632415, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632416, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632417, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632418, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012504', 'increased forebrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632419, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632420, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632421, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632422, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632423, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632424, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632425, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632426, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632427, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632428, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632429, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632430, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632431, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632432, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632433, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632434, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632435, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632436, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632437, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632438, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632439, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632440, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632441, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632442, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632443, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632444, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632445, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632446, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632447, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632448, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632449, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632450, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632451, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632452, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632453, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632454, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632455, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632456, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632457, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632458, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632459, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632460, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632461, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632462, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632463, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632464, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632465, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632466, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632467, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632468, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632469, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632470, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632471, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632472, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632473, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632474, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632475, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632476, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632477, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632478, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632479, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632480, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632481, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632482, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632483, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632484, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632485, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632486, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632487, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632488, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632489, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632490, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632491, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632492, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632493, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632494, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632495, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632496, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632497, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632498, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632499, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632500, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632501, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632502, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632503, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632504, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632505, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632506, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632507, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632508, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632509, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632510, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632511, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632512, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632513, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632514, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001473', 'reduced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632515, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632516, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632517, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632518, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632519, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632520, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632521, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632522, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632523, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632524, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632525, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632526, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632527, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632528, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632529, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009142', 'decreased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632530, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632531, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632532, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632533, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632534, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632535, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000920', 'abnormal myelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632536, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632537, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632538, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632539, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632540, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632541, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632542, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632543, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632544, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632545, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632546, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632547, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632548, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632549, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632550, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632551, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632552, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632553, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003997', 'tonic-clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632554, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632555, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632556, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632557, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632558, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632559, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632560, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632561, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632562, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632563, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632564, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632565, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632566, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632567, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632568, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632569, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632570, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632571, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632572, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632573, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632574, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632575, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632576, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632577, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632578, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632579, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632580, 'HP:0025052', 'Abnormal brain N-acetyl aspartate level by MRS', 'MP:0003471', 'abnormal summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632581, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011483', 'renal glomerular synechia', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632582, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632583, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011506', 'glomerular crescent', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632584, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632585, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011294', 'renal glomerulus hypertrophy', 0.41818181818181815, 9.804092483287297, 2.0248193055884713, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632586, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632587, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011561', 'renal glomerulus lipidosis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632588, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632589, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0020518', 'renal glomerular protein deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632590, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011377', 'renal glomerulus fibrosis', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632591, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4339622641509434, 9.804092483287297, 2.0626696710798362, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632592, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.41304347826086957, 9.692263881549227, 2.000831423648002, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(632593, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0000523', 'cortical renal glomerulopathies', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632594, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0003670', 'dilated renal glomerular capsule', 0.4074074074074074, 9.692263881549227, 1.987133639162305, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(632595, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632596, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632597, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0011567', 'increased renal glomerulus lobularity', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632598, 'HP:0033603', 'Glomerular subepithelial deposits', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(632599, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001208', 'blistering', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632600, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632601, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009603', 'absent keratohyalin granules', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632602, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009385', 'abnormal dermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632603, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009605', 'decreased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632604, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003653', 'decreased skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632605, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632606, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0004241', 'acantholysis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632607, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001196', 'shiny skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632608, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001213', 'abnormal skin cell number', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632609, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632610, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001202', 'skin photosensitivity', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632611, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0031103', 'skin rash', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632612, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0013406', 'abnormal epidermal immune compartment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632613, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008854', 'bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632614, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009604', 'increased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632615, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632616, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003196', 'calcified skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632617, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005421', 'loose skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632618, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632619, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003717', 'pallor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632620, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632621, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001198', 'tight skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632622, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001211', 'wrinkled skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632623, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009606', 'increased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632624, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001209', 'spontaneous skin ulceration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632625, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010300', 'increased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632626, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002060', 'abnormal skin morphology', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632627, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009441', 'delayed skin barrier formation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632628, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632629, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0011239', 'abnormal skin coloration', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632630, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003652', 'abnormal skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632631, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009379', 'abnormal foot pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632632, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001210', 'skin ridges', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632633, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003705', 'abnormal hypodermis morphology', 0.4230769230769231, 6.509554027552121, 1.6595306832293713, 'UPHENO:0002635', 'abnormal integument'),
(632634, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003940', 'abnormal dermatome morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632635, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001191', 'abnormal skin condition', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632636, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632637, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0000377', 'abnormal hair follicle morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632638, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632639, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(632640, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632641, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008816', 'petechiae', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632642, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003941', 'abnormal skin development', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632643, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632644, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0012248', 'absent dermatome', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632645, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632646, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009563', 'dyskeratosis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632647, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632648, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632649, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002897', 'blotchy skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632650, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632651, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009931', 'abnormal skin appearance', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632652, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0000574', 'abnormal foot pad morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632653, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002015', 'epithelioid cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632654, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001197', 'oily skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632655, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632656, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001243', 'abnormal dermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632657, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632658, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0031309', 'skin cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632659, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010206', 'pigment incontinence', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632660, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632661, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0003853', 'dry skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632662, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0011160', 'dermal-epidermal separation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632663, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0014273', 'abnormal skin vasculature morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632664, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632665, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009607', 'decreased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632666, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001193', 'psoriasis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632667, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001195', 'flaky skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632668, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0011515', 'purpura', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632669, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001216', 'abnormal epidermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632670, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009827', 'skin detachment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632671, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001212', 'skin lesions', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632672, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632673, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005501', 'abnormal skin physiology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(632674, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0005174', 'abnormal tail pigmentation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632675, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632676, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632677, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632678, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632679, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632680, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009932', 'skin fibrosis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632681, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632682, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001230', 'epidermal desquamation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632683, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0012078', 'abnormal tail ring morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632684, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632685, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001201', 'translucent skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632686, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0008856', 'fetal bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632687, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010016', 'variable depigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632688, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(632689, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0002095', 'abnormal skin pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632690, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0010285', 'decreased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632691, 'HP:0032676', 'Chronic cutaneous wound', 'MP:0001192', 'scaly skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(632692, 'HP:0100891', 'Bifid xiphoid process', 'MP:0010099', 'abnormal thoracic cage shape', 0.4166666666666667, 10.607147267911275, 2.1022951017787754, 'UPHENO:0087317', 'abnormal thoracic rib cage morphology'),
(632693, 'HP:0011527', 'Lentiglobus', 'MP:0001303', 'abnormal lens morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(632694, 'HP:0011527', 'Lentiglobus', 'MP:0008841', 'ruptured lens capsule', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(632695, 'HP:0011527', 'Lentiglobus', 'MP:0001305', 'enlarged lens', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(632696, 'HP:0011527', 'Lentiglobus', 'MP:0031317', 'spherophakia', 0.41379310344827586, 10.410750055107773, 2.0755472951796, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(632697, 'HP:0011527', 'Lentiglobus', 'MP:0030071', 'abnormal face shape', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632698, 'HP:0011527', 'Lentiglobus', 'MP:0030074', 'coarse facial features', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632699, 'HP:0011527', 'Lentiglobus', 'MP:0001306', 'small lens', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(632700, 'HP:0011527', 'Lentiglobus', 'MP:0006209', 'calcified intraocular region', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(632701, 'HP:0011527', 'Lentiglobus', 'MP:0006225', 'ocular rupture', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(632702, 'HP:0011527', 'Lentiglobus', 'MP:0002697', 'abnormal eye size', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(632703, 'HP:0011527', 'Lentiglobus', 'MP:0030045', 'abnormal forehead shape', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632704, 'HP:0011527', 'Lentiglobus', 'MP:0001319', 'irregularly shaped pupil', 0.41935483870967744, 8.423925443855504, 1.8795249122611737, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(632705, 'HP:0012114', 'Endometrial carcinoma', 'MP:0009092', 'endometrium hyperplasia', 0.40350877192982454, 13.192109768632433, 2.3071913687217873, 'UPHENO:0086566', 'abnormal endometrium morphology'),
(632706, 'HP:0012114', 'Endometrial carcinoma', 'MP:0003571', 'uterus rupture', 0.41509433962264153, 10.87018167374507, 2.124182403524083, 'UPHENO:0076748', 'abnormal uterus morphology'),
(632707, 'HP:0012114', 'Endometrial carcinoma', 'MP:0009359', 'endometrium atrophy', 0.40350877192982454, 13.192109768632433, 2.3071913687217873, 'UPHENO:0086566', 'abnormal endometrium morphology'),
(632708, 'HP:0012114', 'Endometrial carcinoma', 'MP:0013399', 'endometrium fibrosis', 0.4107142857142857, 13.192109768632433, 2.327700139770654, 'UPHENO:0086566', 'abnormal endometrium morphology'),
(632709, 'HP:0012114', 'Endometrial carcinoma', 'MP:0013398', 'uterus fibrosis', 0.41509433962264153, 10.87018167374507, 2.124182403524083, 'UPHENO:0076748', 'abnormal uterus morphology'),
(632710, 'HP:0012114', 'Endometrial carcinoma', 'MP:0004902', 'abnormal uterus size', 0.41509433962264153, 10.87018167374507, 2.124182403524083, 'UPHENO:0076748', 'abnormal uterus morphology'),
(632711, 'HP:0012114', 'Endometrial carcinoma', 'MP:0003568', 'uterus atresia', 0.4074074074074074, 10.87018167374507, 2.1044221377252215, 'UPHENO:0076748', 'abnormal uterus morphology'),
(632712, 'HP:0025668', 'Abnormal neck morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632713, 'HP:0025668', 'Abnormal neck morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632714, 'HP:0025668', 'Abnormal neck morphology', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632715, 'HP:0025668', 'Abnormal neck morphology', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632716, 'HP:0025668', 'Abnormal neck morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632717, 'HP:0025668', 'Abnormal neck morphology', 'MP:0012723', 'abnormal nuchal region morphology', 0.4230769230769231, 10.533898285880637, 2.1110777519541184, 'UPHENO:0003074', 'abnormal neck'),
(632718, 'HP:0025668', 'Abnormal neck morphology', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632719, 'HP:0025668', 'Abnormal neck morphology', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632720, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632721, 'HP:0025668', 'Abnormal neck morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632722, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632723, 'HP:0025668', 'Abnormal neck morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.47619047619047616, 3.8548363184545034, 1.3548565762180114, 'UPHENO:0002764', 'abnormal craniocervical region'),
(632724, 'HP:0025668', 'Abnormal neck morphology', 'MP:0003935', 'abnormal craniofacial development', 0.45454545454545453, 3.8548363184545034, 1.3237062841016616, 'UPHENO:0002764', 'abnormal craniocervical region'),
(632725, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632726, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632727, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632728, 'HP:0025668', 'Abnormal neck morphology', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632729, 'HP:0025668', 'Abnormal neck morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632730, 'HP:0025668', 'Abnormal neck morphology', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632731, 'HP:0025668', 'Abnormal neck morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632732, 'HP:0025668', 'Abnormal neck morphology', 'MP:0012719', 'abnormal neck morphology', 0.4583333333333333, 10.533898285880637, 2.1972793892361433, 'UPHENO:0003074', 'abnormal neck'),
(632733, 'HP:0025668', 'Abnormal neck morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632734, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632735, 'HP:0025668', 'Abnormal neck morphology', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632736, 'HP:0025668', 'Abnormal neck morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632737, 'HP:0025668', 'Abnormal neck morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632738, 'HP:0025668', 'Abnormal neck morphology', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632739, 'HP:0025668', 'Abnormal neck morphology', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632740, 'HP:0025668', 'Abnormal neck morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632741, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632742, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632743, 'HP:0025668', 'Abnormal neck morphology', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632744, 'HP:0025668', 'Abnormal neck morphology', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632745, 'HP:0025668', 'Abnormal neck morphology', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632746, 'HP:0025668', 'Abnormal neck morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632747, 'HP:0025668', 'Abnormal neck morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632748, 'HP:0025668', 'Abnormal neck morphology', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632749, 'HP:0025668', 'Abnormal neck morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632750, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632751, 'HP:0025668', 'Abnormal neck morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632752, 'HP:0025668', 'Abnormal neck morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(632753, 'HP:0003963', 'Lytic defects of the forearm bones', 'MP:0005108', 'abnormal ulna morphology', 0.43137254901960786, 10.120647406075808, 2.089442382380429, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(632754, 'HP:0003963', 'Lytic defects of the forearm bones', 'MP:0000552', 'abnormal radius morphology', 0.43137254901960786, 10.120647406075808, 2.089442382380429, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(632755, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0002136', 'abnormal kidney physiology', 0.53125, 10.834557764014349, 2.3991370974024435, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632756, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011447', 'abnormal renal glucose reabsorption', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632757, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632758, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0010110', 'abnormal renal phosphate reabsorption', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632759, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0013305', 'isosthenuria', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632760, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011404', 'pyelitis', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632761, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005530', 'decreased renal vascular resistance', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632762, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011368', 'increased kidney apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632763, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0021055', 'decreased renal arterial blood pressure', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632764, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0003606', 'kidney failure', 0.4857142857142857, 10.834557764014349, 2.294013837224701, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632765, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011446', 'abnormal renal albumin reabsorption', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632766, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632767, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011442', 'abnormal renal sodium ion transport', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632768, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004040', 'abnormal susceptibility to kidney reperfusion injury', 0.4857142857142857, 10.834557764014349, 2.294013837224701, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632769, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0021054', 'increased renal arterial blood pressure', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632770, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005557', 'increased creatinine clearance', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632771, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0010107', 'abnormal renal reabsorption', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632772, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011445', 'abnormal renal protein reabsorption', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632773, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011371', 'decreased kidney apoptosis', 0.40476190476190477, 10.834557764014349, 2.0941385431282553, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632774, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005558', 'decreased creatinine clearance', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632775, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0002708', 'nephrolithiasis', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632776, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011444', 'abnormal renal water homeostasis', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632777, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011441', 'decreased kidney cell proliferation', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632778, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0010108', 'abnormal renal water reabsorption', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632779, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0013285', 'abnormal renal filtration', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632780, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0001756', 'abnormal urination', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632781, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632782, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0000533', 'kidney hemorrhage', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632783, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0010109', 'abnormal renal sodium reabsorption', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632784, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632785, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0003621', 'dysuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632786, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0000525', 'renal tubular acidosis', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632787, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0001761', 'abnormal urination pattern', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632788, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632789, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011417', 'abnormal renal transport', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632790, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011443', 'abnormal renal water transport', 0.4857142857142857, 10.834557764014349, 2.294013837224701, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632791, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011856', 'abnormal glomerular filtration barrier function', 0.4857142857142857, 10.834557764014349, 2.294013837224701, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632792, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632793, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0003589', 'abnormal ureter physiology', 0.42857142857142855, 8.666588959537362, 1.9272395832460214, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632794, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011440', 'increased kidney cell proliferation', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632795, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0001859', 'kidney inflammation', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632796, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005529', 'abnormal renal vascular resistance', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632797, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0003280', 'urinary incontinence', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632798, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011432', 'decreased urine flow rate', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632799, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004042', 'decreased susceptibility to kidney reperfusion injury', 0.4594594594594595, 10.834557764014349, 2.231152180765876, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632800, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632801, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011405', 'tubulointerstitial nephritis', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632802, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011431', 'increased urine flow rate', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632803, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0001948', 'vesicoureteral reflux', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632804, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632805, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005556', 'abnormal renal filtration rate', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632806, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011439', 'abnormal kidney cell proliferation', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632807, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011367', 'abnormal kidney apoptosis', 0.4358974358974359, 10.834557764014349, 2.1731902697224905, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632808, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011403', 'pyelonephritis', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632809, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004041', 'increased susceptibility to kidney reperfusion injury', 0.4722222222222222, 10.834557764014349, 2.261928147425971, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632810, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0013284', 'abnormal renal glomerular filtration', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632811, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0005531', 'increased renal vascular resistance', 0.425, 10.834557764014349, 2.145853454853359, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632812, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011437', 'glomerulus hemorrhage', 0.4146341463414634, 10.834557764014349, 2.119522967431437, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632813, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.5, 10.834557764014349, 2.3275048618654215, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632814, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0012576', 'abnormal kidney glutathione peroxidase activity', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632815, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0009643', 'abnormal urine homeostasis', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632816, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0011758', 'renal ischemia', 0.5151515151515151, 10.834557764014349, 2.3625068990647633, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632817, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0010111', 'abnormal renal calcium reabsorption', 0.4473684210526316, 10.834557764014349, 2.201599191426684, 'UPHENO:0002411', 'abnormality of kidney physiology'),
(632818, 'HP:0025647', 'Steroid-sensitive nephrotic syndrome', 'MP:0014037', 'stranguria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(632819, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632820, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632821, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632822, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632823, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632824, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632825, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632826, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632827, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632828, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632829, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632830, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632831, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632832, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632833, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632834, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632835, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632836, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632837, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632838, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632839, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632840, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632841, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632842, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632843, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632844, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632845, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632846, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632847, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632848, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632849, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632850, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632851, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632852, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632853, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632854, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632855, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632856, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632857, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632858, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632859, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632860, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632861, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632862, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632863, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632864, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632865, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632866, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632867, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632868, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632869, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632870, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632871, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632872, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632873, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632874, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632875, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632876, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632877, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632878, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632879, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632880, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632881, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632882, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632883, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632884, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632885, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632886, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632887, 'HP:0012557', 'EEG with centrotemporal focal spike waves', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632888, 'HP:0000291', 'Abnormality of facial adipose tissue', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(632889, 'HP:0000291', 'Abnormality of facial adipose tissue', 'MP:0005457', 'abnormal percent body fat/body weight', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(632890, 'HP:0000291', 'Abnormality of facial adipose tissue', 'MP:0011174', 'lipodystrophy', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(632891, 'HP:0000291', 'Abnormality of facial adipose tissue', 'MP:0011167', 'abnormal adipose tissue development', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(632892, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632893, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632894, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632895, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632896, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632897, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632898, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632899, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632900, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632901, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632902, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632903, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632904, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632905, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632906, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632907, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632908, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632909, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632910, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632911, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632912, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632913, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632914, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632915, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632916, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632917, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632918, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632919, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632920, 'HP:0032751', 'Focal impaired awareness emotional seizure with crying', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(632921, 'HP:0410175', 'Hyperketonemia', 'MP:0030970', 'ketosis', 0.43137254901960786, 13.491670050491338, 2.4124543726694503, 'UPHENO:0055032', 'increased ketone body biosynthetic process'),
(632922, 'HP:0410175', 'Hyperketonemia', 'MP:0002575', 'increased circulating ketone body level', 0.4117647058823529, 13.491670050491338, 2.356988237179455, 'UPHENO:0055032', 'increased ketone body biosynthetic process'),
(632923, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0004818', 'increased skeletal muscle mass', 0.43333333333333335, 9.847813860716615, 2.0657652350425817, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632924, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0004819', 'decreased skeletal muscle mass', 0.43333333333333335, 9.847813860716615, 2.0657652350425817, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632925, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000733', 'abnormal muscle development', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632926, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.43333333333333335, 9.847813860716615, 2.0657652350425817, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632927, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000731', 'increased collagen deposition in the muscles', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632928, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0002108', 'abnormal muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632929, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000736', 'delayed muscle development', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632930, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000767', 'abnormal smooth muscle morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632931, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.4642857142857143, 9.847813860716615, 2.1382701635844734, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632932, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632933, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0009407', 'increased skeletal muscle fiber density', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632934, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.43333333333333335, 9.847813860716615, 2.0657652350425817, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632935, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0000752', 'dystrophic muscle', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(632936, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0031112', 'rhabdomyolysis', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632937, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0004817', 'abnormal skeletal muscle mass', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632938, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.4482758620689655, 9.847813860716615, 2.10108001939656, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632939, 'HP:0100303', 'Muscle fiber cytoplasmatic inclusion bodies', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.40625, 9.847813860716615, 2.0001685881235423, 'UPHENO:0087047', 'abnormal skeletal muscle tissue morphology'),
(632940, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0009986', 'abnormal middle cerebellar peduncle morphology', 0.4074074074074074, 12.799792345853673, 2.2835783794250246, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(632941, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0020565', 'abnormal pontocerebellar fibers size', 0.4262295081967213, 12.799792345853673, 2.335733117587146, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(632942, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0012262', 'abnormal hindbrain size', 0.40816326530612246, 10.879226813348076, 2.107249567598027, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(632943, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0009987', 'abnormal superior cerebellar peduncle morphology', 0.4230769230769231, 12.799792345853673, 2.3270790192228805, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(632944, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0020532', 'abnormal pons size', 0.4117647058823529, 9.537473740104465, 1.9817151837372542, 'UPHENO:0076808', 'abnormal brainstem morphology'),
(632945, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0009985', 'abnormal inferior cerebellar peduncle morphology', 0.41509433962264153, 12.799792345853673, 2.3050209003627433, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(632946, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0009976', 'abnormal cerebellar peduncle morphology', 0.44, 12.799792345853673, 2.3731642657379655, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(632947, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0000852', 'small cerebellum', 0.4117647058823529, 9.732678149995134, 2.00189244363436, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(632948, 'HP:0011931', 'Abnormal cerebellar peduncle morphology', 'MP:0008914', 'enlarged cerebellum', 0.4117647058823529, 9.732678149995134, 2.00189244363436, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(632949, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0003735', 'cup-shaped ears', 0.4807692307692308, 11.115294171581601, 2.3116858412520074, 'UPHENO:0005986', 'abnormal shape of external ear'),
(632950, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0006290', 'proboscis', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632951, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0000018', 'small ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(632952, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0011495', 'abnormal head shape', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632953, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0000022', 'abnormal ear shape', 0.5434782608695652, 11.115294171581601, 2.457828461350544, 'UPHENO:0005986', 'abnormal shape of external ear'),
(632954, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0030071', 'abnormal face shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632955, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0003736', 'folded helix', 0.43859649122807015, 11.115294171581601, 2.20796943425934, 'UPHENO:0005986', 'abnormal shape of external ear'),
(632956, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0000053', 'excessive ear growth', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(632957, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0009578', 'otocephaly', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(632958, 'HP:0011237', 'Broad inferior crus of antihelix', 'MP:0000017', 'big ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(632959, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632960, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632961, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632962, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632963, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632964, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632965, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632966, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632967, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632968, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632969, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632970, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632971, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632972, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632973, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632974, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632975, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632976, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632977, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632978, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632979, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632980, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632981, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632982, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632983, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632984, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632985, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632986, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632987, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632988, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632989, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632990, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632991, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632992, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632993, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632994, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632995, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632996, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(632997, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632998, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(632999, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633000, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633001, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633002, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633003, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633004, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633005, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633006, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633007, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633008, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633009, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633010, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633011, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633012, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633013, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633014, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633015, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633016, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633017, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633018, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633019, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633020, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633021, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633022, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633023, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633024, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633025, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633026, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633027, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633028, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633029, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633030, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633031, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633032, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633033, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633034, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633035, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633036, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633037, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633038, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633039, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633040, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633041, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633042, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633043, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633044, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633045, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633046, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633047, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633048, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633049, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633050, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633051, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633052, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633053, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633054, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633055, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633056, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633057, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633058, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633059, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633060, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633061, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633062, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633063, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633064, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633065, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633066, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633067, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633068, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633069, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633070, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633071, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633072, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633073, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633074, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633075, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633076, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633077, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633078, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633079, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633080, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633081, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633082, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633083, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633084, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633085, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633086, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633087, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633088, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633089, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633090, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633091, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633092, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633093, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633094, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633095, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633096, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633097, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633098, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633099, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633100, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633101, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633102, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633103, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633104, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633105, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633106, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633107, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633108, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633109, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633110, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633111, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633112, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633113, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633114, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633115, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633116, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633117, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633118, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633119, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633120, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633121, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633122, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633123, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633124, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633125, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633126, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633127, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633128, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633129, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633130, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633131, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633132, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633133, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633134, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633135, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633136, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633137, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633138, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633139, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633140, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633141, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633142, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633143, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633144, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633145, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633146, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633147, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633148, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633149, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633150, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633151, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633152, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633153, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633154, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633155, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633156, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633157, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633158, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633159, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633160, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633161, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633162, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633163, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633164, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633165, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633166, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633167, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633168, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633169, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633170, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633171, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633172, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633173, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633174, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633175, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633176, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633177, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633178, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633179, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633180, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633181, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633182, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633183, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633184, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633185, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633186, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633187, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633188, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633189, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633190, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633191, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633192, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633193, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633194, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633195, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633196, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633197, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633198, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633199, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633200, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633201, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633202, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633203, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633204, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633205, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633206, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633207, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633208, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633209, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633210, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633211, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633212, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633213, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633214, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633215, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633216, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633217, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633218, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633219, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633220, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633221, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633222, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633223, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633224, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633225, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633226, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633227, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633228, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633229, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633230, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633231, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633232, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633233, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633234, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633235, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633236, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633237, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633238, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633239, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633240, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633241, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633242, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633243, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633244, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633245, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633246, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633247, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633248, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633249, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633250, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633251, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633252, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633253, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633254, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633255, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633256, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633257, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633258, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633259, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633260, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633261, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633262, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633263, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633264, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633265, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633266, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633267, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633268, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633269, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633270, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633271, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633272, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633273, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633274, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633275, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633276, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633277, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633278, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633279, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633280, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633281, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633282, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633283, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633284, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633285, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633286, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633287, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633288, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633289, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633290, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633291, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633292, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633293, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633294, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633295, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633296, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633297, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633298, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633299, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633300, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633301, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633302, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633303, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633304, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633305, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633306, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633307, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633308, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633309, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633310, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633311, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633312, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633313, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633314, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633315, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633316, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633317, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633318, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633319, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633320, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633321, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633322, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633323, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633324, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633325, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633326, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633327, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633328, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633329, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633330, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633331, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633332, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633333, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633334, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633335, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633336, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633337, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633338, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633339, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633340, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633341, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633342, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633343, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633344, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633345, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633346, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633347, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633348, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633349, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633350, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633351, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633352, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633353, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633354, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633355, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633356, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633357, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633358, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633359, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633360, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633361, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633362, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633363, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633364, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633365, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633366, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633367, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633368, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633369, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633370, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633371, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633372, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633373, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633374, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633375, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633376, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633377, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633378, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633379, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633380, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633381, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633382, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633383, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633384, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633385, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633386, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633387, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633388, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633389, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633390, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633391, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633392, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633393, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633394, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633395, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633396, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633397, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633398, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633399, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633400, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633401, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633402, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633403, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633404, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633405, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633406, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633407, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633408, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633409, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633410, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633411, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633412, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633413, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633414, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633415, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633416, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633417, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633418, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633419, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633420, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633421, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633422, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633423, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633424, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633425, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633426, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633427, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633428, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633429, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633430, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633431, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633432, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633433, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633434, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633435, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633436, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633437, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633438, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633439, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633440, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633441, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633442, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633443, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633444, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633445, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633446, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633447, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633448, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633449, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633450, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633451, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633452, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633453, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633454, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633455, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633456, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633457, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633458, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633459, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633460, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633461, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633462, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633463, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633464, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633465, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633466, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633467, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633468, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633469, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633470, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633471, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633472, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633473, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633474, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633475, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633476, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633477, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633478, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633479, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633480, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633481, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633482, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633483, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633484, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633485, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633486, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633487, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633488, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633489, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633490, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633491, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633492, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633493, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633494, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633495, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633496, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633497, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633498, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633499, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633500, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633501, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633502, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633503, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633504, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633505, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633506, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633507, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633508, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633509, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633510, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633511, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633512, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633513, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633514, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633515, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633516, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633517, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633518, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633519, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633520, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633521, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633522, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633523, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633524, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633525, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633526, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633527, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633528, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633529, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633530, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633531, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633532, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633533, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633534, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633535, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633536, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633537, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633538, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633539, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633540, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633541, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633542, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633543, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633544, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633545, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633546, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633547, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633548, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633549, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633550, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633551, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633552, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633553, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633554, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633555, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633556, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633557, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633558, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633559, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633560, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633561, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633562, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633563, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633564, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633565, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633566, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633567, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633568, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633569, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633570, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633571, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633572, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633573, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633574, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633575, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633576, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633577, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633578, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633579, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633580, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633581, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633582, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633583, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633584, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633585, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633586, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633587, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633588, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633589, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633590, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633591, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633592, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633593, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633594, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633595, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633596, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633597, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633598, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633599, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633600, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633601, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633602, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633603, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633604, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633605, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633606, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633607, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633608, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633609, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633610, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633611, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633612, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633613, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633614, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633615, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633616, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633617, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633618, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633619, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633620, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633621, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633622, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633623, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633624, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633625, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633626, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633627, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633628, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633629, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633630, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633631, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633632, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633633, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633634, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633635, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633636, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633637, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633638, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633639, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633640, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633641, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633642, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633643, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633644, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633645, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633646, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633647, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633648, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633649, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633650, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633651, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633652, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633653, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633654, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633655, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633656, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633657, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633658, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633659, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633660, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633661, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633662, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633663, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633664, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633665, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633666, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633667, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633668, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633669, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633670, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633671, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633672, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633673, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633674, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633675, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633676, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633677, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633678, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633679, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633680, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633681, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633682, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633683, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633684, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633685, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633686, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633687, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633688, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633689, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633690, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633691, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633692, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633693, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633694, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633695, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633696, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633697, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633698, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633699, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633700, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633701, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633702, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633703, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633704, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633705, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633706, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(633707, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633708, 'HP:0034066', 'Anti-carbonic anhydrase VI antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(633709, 'HP:0004439', 'Craniofacial dysostosis', 'MP:0000919', 'cranioschisis', 0.42, 7.173214147510782, 1.7357274964563212, 'UPHENO:0081566', 'abnormal skull morphology'),
(633710, 'HP:0004439', 'Craniofacial dysostosis', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(633711, 'HP:0004439', 'Craniofacial dysostosis', 'MP:0010031', 'abnormal cranium size', 0.42857142857142855, 7.173214147510782, 1.7533495471945912, 'UPHENO:0081566', 'abnormal skull morphology'),
(633712, 'HP:0004377', 'Hematological neoplasm', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633713, 'HP:0004377', 'Hematological neoplasm', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633714, 'HP:0004377', 'Hematological neoplasm', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633715, 'HP:0004377', 'Hematological neoplasm', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633716, 'HP:0004377', 'Hematological neoplasm', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633717, 'HP:0004377', 'Hematological neoplasm', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633718, 'HP:0004377', 'Hematological neoplasm', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633719, 'HP:0004377', 'Hematological neoplasm', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633720, 'HP:0004377', 'Hematological neoplasm', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.43478260869565216, 5.816527256141925, 1.590259379464479, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(633721, 'HP:0004377', 'Hematological neoplasm', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633722, 'HP:0004377', 'Hematological neoplasm', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633723, 'HP:0004377', 'Hematological neoplasm', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633724, 'HP:0004377', 'Hematological neoplasm', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633725, 'HP:0004377', 'Hematological neoplasm', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633726, 'HP:0004377', 'Hematological neoplasm', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633727, 'HP:0004377', 'Hematological neoplasm', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633728, 'HP:0004377', 'Hematological neoplasm', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633729, 'HP:0004377', 'Hematological neoplasm', 'MP:0012382', 'abnormal blood cell physiology', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(633730, 'HP:0004377', 'Hematological neoplasm', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633731, 'HP:0004377', 'Hematological neoplasm', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633732, 'HP:0004377', 'Hematological neoplasm', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633733, 'HP:0004377', 'Hematological neoplasm', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633734, 'HP:0004377', 'Hematological neoplasm', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633735, 'HP:0004377', 'Hematological neoplasm', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633736, 'HP:0004377', 'Hematological neoplasm', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633737, 'HP:0004377', 'Hematological neoplasm', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633738, 'HP:0004377', 'Hematological neoplasm', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633739, 'HP:0004377', 'Hematological neoplasm', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633740, 'HP:0004377', 'Hematological neoplasm', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633741, 'HP:0004377', 'Hematological neoplasm', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633742, 'HP:0004377', 'Hematological neoplasm', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633743, 'HP:0004377', 'Hematological neoplasm', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633744, 'HP:0004377', 'Hematological neoplasm', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633745, 'HP:0004377', 'Hematological neoplasm', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633746, 'HP:0004377', 'Hematological neoplasm', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633747, 'HP:0004377', 'Hematological neoplasm', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633748, 'HP:0004377', 'Hematological neoplasm', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633749, 'HP:0004377', 'Hematological neoplasm', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.47619047619047616, 5.816527256141925, 1.6642640667505584, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(633750, 'HP:0004377', 'Hematological neoplasm', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633751, 'HP:0004377', 'Hematological neoplasm', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(633752, 'HP:0100009', 'Intracranial meningioma', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.40540540540540543, 12.214829845132515, 2.225299540584142, 'UPHENO:0075672', 'abnormal meninx'),
(633753, 'HP:0100009', 'Intracranial meningioma', 'MP:0000771', 'abnormal brain size', 0.41025641025641024, 5.838687225017717, 1.54769469261406, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(633754, 'HP:0100009', 'Intracranial meningioma', 'MP:0030014', 'calcified brain', 0.41025641025641024, 5.838687225017717, 1.54769469261406, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(633755, 'HP:0001274', 'Agenesis of corpus callosum', 'MP:0008223', 'absent hippocampal commissure', 0.4189189189189189, 12.437222266468964, 2.2825835595271173, 'UPHENO:0087750', 'abnormal dorsal telencephalic commissure morphology'),
(633756, 'HP:0001274', 'Agenesis of corpus callosum', 'MP:0002196', 'absent corpus callosum', 0.4657534246575342, 16.19210976863243, 2.7461847310716863, 'UPHENO:0008622', 'absent corpus callosum'),
(633757, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012262', 'abnormal hindbrain size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(633758, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000831', 'diencephalon hyperplasia', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633759, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0004101', 'abnormal brain interneuron morphology', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(633760, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633761, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0002741', 'small olfactory bulb', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633762, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000791', 'delaminated cerebral cortex', 0.45454545454545453, 8.100674382308824, 1.918886322644279, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633763, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000774', 'decreased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(633764, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020569', 'abnormal premotor cortex size', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633765, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012138', 'decreased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(633766, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012468', 'decreased striatum size', 0.4166666666666667, 8.100674382308824, 1.8371937820025075, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633767, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.41025641025641024, 8.100674382308824, 1.823006745117001, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633768, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000787', 'abnormal telencephalon morphology', 0.43243243243243246, 8.100674382308824, 1.8716287899807742, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633769, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0013229', 'abnormal brain ventricle size', 0.42857142857142855, 6.72807461644252, 1.698075543049819, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(633770, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020141', 'decreased brain external capsule size', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633771, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0005238', 'increased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(633772, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020530', 'disorganized thalamus', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633773, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000785', 'telencephalon hypoplasia', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633774, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000783', 'abnormal forebrain morphology', 0.4166666666666667, 7.13344151829186, 1.724026478708571, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633775, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0011854', 'cerebral edema', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(633776, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020525', 'abnormal thalamus size', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633777, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000771', 'abnormal brain size', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(633778, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020066', 'abnormal neocortex size', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633779, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012139', 'increased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(633780, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012092', 'diencephalon hypoplasia', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(633781, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0006254', 'thin cerebral cortex', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633782, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0030014', 'calcified brain', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(633783, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012137', 'abnormal forebrain size', 0.4878048780487805, 9.371930806217245, 2.1381472269253146, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(633784, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012088', 'abnormal midbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(633785, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012775', 'abnormal brain weight', 0.4146341463414634, 6.213399309526074, 1.605081779406888, 'UPHENO:0076805', 'abnormal brain morphology'),
(633786, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0010058', 'enlarged olfactory bulb', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633787, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0000789', 'thickened cerebral cortex', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633788, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0012467', 'increased striatum size', 0.4166666666666667, 8.100674382308824, 1.8371937820025075, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633789, 'HP:0025702', 'Type 1 schizencephaly', 'MP:0020140', 'increased brain external capsule size', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(633790, 'HP:0031293', 'Digital pitting scar', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633791, 'HP:0031293', 'Digital pitting scar', 'MP:0003717', 'pallor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633792, 'HP:0031293', 'Digital pitting scar', 'MP:0012078', 'abnormal tail ring morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633793, 'HP:0031293', 'Digital pitting scar', 'MP:0003652', 'abnormal skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633794, 'HP:0031293', 'Digital pitting scar', 'MP:0009827', 'skin detachment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633795, 'HP:0031293', 'Digital pitting scar', 'MP:0004241', 'acantholysis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633796, 'HP:0031293', 'Digital pitting scar', 'MP:0005174', 'abnormal tail pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633797, 'HP:0031293', 'Digital pitting scar', 'MP:0009385', 'abnormal dermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633798, 'HP:0031293', 'Digital pitting scar', 'MP:0009605', 'decreased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633799, 'HP:0031293', 'Digital pitting scar', 'MP:0001210', 'skin ridges', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633800, 'HP:0031293', 'Digital pitting scar', 'MP:0001211', 'wrinkled skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633801, 'HP:0031293', 'Digital pitting scar', 'MP:0009379', 'abnormal foot pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633802, 'HP:0031293', 'Digital pitting scar', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633803, 'HP:0031293', 'Digital pitting scar', 'MP:0013406', 'abnormal epidermal immune compartment', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633804, 'HP:0031293', 'Digital pitting scar', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633805, 'HP:0031293', 'Digital pitting scar', 'MP:0002897', 'blotchy skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633806, 'HP:0031293', 'Digital pitting scar', 'MP:0002060', 'abnormal skin morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633807, 'HP:0031293', 'Digital pitting scar', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633808, 'HP:0031293', 'Digital pitting scar', 'MP:0001192', 'scaly skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633809, 'HP:0031293', 'Digital pitting scar', 'MP:0001209', 'spontaneous skin ulceration', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633810, 'HP:0031293', 'Digital pitting scar', 'MP:0001208', 'blistering', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633811, 'HP:0031293', 'Digital pitting scar', 'MP:0001196', 'shiny skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633812, 'HP:0031293', 'Digital pitting scar', 'MP:0001230', 'epidermal desquamation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633813, 'HP:0031293', 'Digital pitting scar', 'MP:0009932', 'skin fibrosis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633814, 'HP:0031293', 'Digital pitting scar', 'MP:0001212', 'skin lesions', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633815, 'HP:0031293', 'Digital pitting scar', 'MP:0003853', 'dry skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633816, 'HP:0031293', 'Digital pitting scar', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633817, 'HP:0031293', 'Digital pitting scar', 'MP:0001202', 'skin photosensitivity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633818, 'HP:0031293', 'Digital pitting scar', 'MP:0031103', 'skin rash', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633819, 'HP:0031293', 'Digital pitting scar', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633820, 'HP:0031293', 'Digital pitting scar', 'MP:0003196', 'calcified skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633821, 'HP:0031293', 'Digital pitting scar', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633822, 'HP:0031293', 'Digital pitting scar', 'MP:0011515', 'purpura', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633823, 'HP:0031293', 'Digital pitting scar', 'MP:0000367', 'abnormal coat/ hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(633824, 'HP:0031293', 'Digital pitting scar', 'MP:0003653', 'decreased skin turgor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633825, 'HP:0031293', 'Digital pitting scar', 'MP:0001195', 'flaky skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633826, 'HP:0031293', 'Digital pitting scar', 'MP:0009604', 'increased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633827, 'HP:0031293', 'Digital pitting scar', 'MP:0001201', 'translucent skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633828, 'HP:0031293', 'Digital pitting scar', 'MP:0002015', 'epithelioid cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633829, 'HP:0031293', 'Digital pitting scar', 'MP:0001213', 'abnormal skin cell number', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633830, 'HP:0031293', 'Digital pitting scar', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633831, 'HP:0031293', 'Digital pitting scar', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633832, 'HP:0031293', 'Digital pitting scar', 'MP:0008854', 'bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633833, 'HP:0031293', 'Digital pitting scar', 'MP:0001216', 'abnormal epidermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633834, 'HP:0031293', 'Digital pitting scar', 'MP:0003705', 'abnormal hypodermis morphology', 0.4074074074074074, 6.509554027552121, 1.6285086827350528, 'UPHENO:0002635', 'abnormal integument'),
(633835, 'HP:0031293', 'Digital pitting scar', 'MP:0008816', 'petechiae', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633836, 'HP:0031293', 'Digital pitting scar', 'MP:0002095', 'abnormal skin pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633837, 'HP:0031293', 'Digital pitting scar', 'MP:0011160', 'dermal-epidermal separation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633838, 'HP:0031293', 'Digital pitting scar', 'MP:0001198', 'tight skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633839, 'HP:0031293', 'Digital pitting scar', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633840, 'HP:0031293', 'Digital pitting scar', 'MP:0003941', 'abnormal skin development', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633841, 'HP:0031293', 'Digital pitting scar', 'MP:0009441', 'delayed skin barrier formation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633842, 'HP:0031293', 'Digital pitting scar', 'MP:0009603', 'absent keratohyalin granules', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633843, 'HP:0031293', 'Digital pitting scar', 'MP:0009931', 'abnormal skin appearance', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633844, 'HP:0031293', 'Digital pitting scar', 'MP:0009606', 'increased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633845, 'HP:0031293', 'Digital pitting scar', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633846, 'HP:0031293', 'Digital pitting scar', 'MP:0001191', 'abnormal skin condition', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633847, 'HP:0031293', 'Digital pitting scar', 'MP:0009607', 'decreased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633848, 'HP:0031293', 'Digital pitting scar', 'MP:0010206', 'pigment incontinence', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633849, 'HP:0031293', 'Digital pitting scar', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633850, 'HP:0031293', 'Digital pitting scar', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633851, 'HP:0031293', 'Digital pitting scar', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633852, 'HP:0031293', 'Digital pitting scar', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633853, 'HP:0031293', 'Digital pitting scar', 'MP:0001193', 'psoriasis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633854, 'HP:0031293', 'Digital pitting scar', 'MP:0009563', 'dyskeratosis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633855, 'HP:0031293', 'Digital pitting scar', 'MP:0011239', 'abnormal skin coloration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633856, 'HP:0031293', 'Digital pitting scar', 'MP:0010016', 'variable depigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633857, 'HP:0031293', 'Digital pitting scar', 'MP:0005421', 'loose skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633858, 'HP:0031293', 'Digital pitting scar', 'MP:0003940', 'abnormal dermatome morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633859, 'HP:0031293', 'Digital pitting scar', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633860, 'HP:0031293', 'Digital pitting scar', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633861, 'HP:0031293', 'Digital pitting scar', 'MP:0031309', 'skin cyst', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633862, 'HP:0031293', 'Digital pitting scar', 'MP:0001243', 'abnormal dermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633863, 'HP:0031293', 'Digital pitting scar', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633864, 'HP:0031293', 'Digital pitting scar', 'MP:0008856', 'fetal bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(633865, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009018', 'short estrus', 0.42105263157894735, 10.972941248170269, 2.1494617439496966, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633866, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009019', 'abnormal metestrus', 0.43243243243243246, 10.972941248170269, 2.1783148704639648, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633867, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009662', 'abnormal uterine receptivity', 0.43243243243243246, 10.972941248170269, 2.1783148704639648, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633868, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0002907', 'abnormal parturition', 0.4444444444444444, 10.972941248170269, 2.208362012208271, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633869, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0001927', 'abnormal estrous cycle', 0.4444444444444444, 10.972941248170269, 2.208362012208271, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633870, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009017', 'prolonged estrus', 0.42105263157894735, 10.972941248170269, 2.1494617439496966, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633871, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0012018', 'abnormal oviduct physiology', 0.43243243243243246, 10.972941248170269, 2.1783148704639648, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633872, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0003699', 'abnormal female reproductive system physiology', 0.47058823529411764, 10.972941248170269, 2.272385763457094, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633873, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0003376', 'amenorrhea', 0.41025641025641024, 10.972941248170269, 2.1217255916891866, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633874, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009015', 'short proestrus', 0.42105263157894735, 10.972941248170269, 2.1494617439496966, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(633875, 'HP:0030012', 'Abnormal female reproductive system physiology', 'MP:0009014', 'prolonged proestrus', 0.42105263157894735, 10.972941248170269, 2.1494617439496966, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
